Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amedica buys US Spine for sales boost

This article was originally published in Clinica

Executive Summary

Spinal implant firm Amedica has doubled the size of its distribution network and bolstered its international presence after purchasing US Spine for an undisclosed fee. The deal sees Amedica gain US Spine’s complementary facet technologies for open, minimally-invasive surgery, allograft and deformity correction procedures. US Spine (Boca Ranton, Florida) manufactures the Javelin minimally-invasive locking facet system, the Phantom Plus transforaminal lumbar interbody fusion/posterior lumbar interbody fusion, cervical and classic spine peek spacers and the Preference 2 spine system. Salt Lake City, Utah-based Amedica said the transaction would allow it to provide customers with a full line of spinal products, including its own implants made from fracture-resistant silicon nitride material. The firm’s implants are “BioActive” and have a hydrophilic microstructure surface that enhances bone in-growth.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095659

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel